λ-Crystallin inhibitors represent a specialized class of chemical compounds that interact with λ-crystallin, a protein primarily found in the lens of certain vertebrates, including mammals and birds. λ-Crystallin is functionally related to enzymes like lactate dehydrogenase (LDH), and this connection provides a basis for its dual role in both structural support within the eye lens and enzymatic activity. λ-Crystallin's structural role is crucial for maintaining lens transparency and refractive properties, while its enzymatic activity influences metabolic pathways, particularly in relation to the handling of lactate and other metabolic intermediates. Inhibitors targeting λ-crystallin are designed to modulate these protein interactions, thereby potentially affecting both the structural integrity and the metabolic processes within cells expressing this protein.
The chemical nature of λ-crystallin inhibitors varies widely, encompassing a range of organic and inorganic molecules that can specifically bind to and alter the function of λ-crystallin. These inhibitors can function through different mechanisms, such as competitive inhibition, where the inhibitor competes with the natural substrate of the enzyme, or through allosteric modulation, where the inhibitor binds to a site other than the active site, causing a conformational change that reduces enzymatic activity. Additionally, some inhibitors may induce conformational changes that destabilize the structural properties of λ-crystallin, which can affect its role in maintaining lens transparency. The design and study of these inhibitors often involve detailed understanding of the three-dimensional structure of λ-crystallin and its active sites, achieved through techniques such as X-ray crystallography and nuclear magnetic resonance (NMR) spectroscopy. Understanding the precise interactions at the molecular level helps in elucidating the binding affinity and specificity of these inhibitors, which is crucial for advancing our knowledge of protein function and structure in ocular biology and beyond.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
D-Sorbitol | 50-70-4 | sc-203278A sc-203278 | 100 g 1 kg | $29.00 $69.00 | ||
Increases osmotic stress in lens cells, potentially destabilizing γ-Crystallin. | ||||||
D-Galactose | 59-23-4 | sc-202564 | 100 g | $288.00 | 4 | |
Induces galactosemia, which can disrupt lens clarity and affect crystallin proteins. | ||||||
Methylglyoxal solution | 78-98-8 | sc-250394 sc-250394A sc-250394B sc-250394C sc-250394D | 25 ml 100 ml 250 ml 500 ml 1 L | $146.00 $437.00 $478.00 $754.00 $1446.00 | 3 | |
Forms advanced glycation end products (AGEs) that can modify γ-Crystallin. | ||||||
Hydrogen Peroxide | 7722-84-1 | sc-203336 sc-203336A sc-203336B | 100 ml 500 ml 3.8 L | $31.00 $61.00 $95.00 | 28 | |
Causes oxidative stress, potentially affecting γ-Crystallin structure. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Glucocorticoid that can influence lens protein expression and stability. | ||||||
Sodium selenite | 10102-18-8 | sc-253595 sc-253595B sc-253595C sc-253595A | 5 g 500 g 1 kg 100 g | $49.00 $183.00 $316.00 $98.00 | 3 | |
Induces oxidative stress in lens cells, potentially altering γ-Crystallin. | ||||||
Paraquat chloride | 1910-42-5 | sc-257968 | 250 mg | $168.00 | 7 | |
Generates reactive oxygen species, affecting lens proteins. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Induces ER stress, potentially affecting protein folding in the lens. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
Induces ER stress and affects protein glycosylation, potentially impacting γ-Crystallin. | ||||||
Cadmium chloride, anhydrous | 10108-64-2 | sc-252533 sc-252533A sc-252533B | 10 g 50 g 500 g | $56.00 $183.00 $352.00 | 1 | |
Toxic metal that can affect lens clarity and protein structure. | ||||||